arrow
T

Thomas Battaglia

Netherlands Cancer Institute
H指数:20
被引数:3,540

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol
2024-07-180
PRE
Characterization of discordance between mismatch repair deficiency and microsatellite instability testing may prevent inappropriate treatment with immunotherapy
2024-05-151
PRE
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

durvalumab在错配修复缺陷或微卫星不稳定性高的实体瘤患者中的疗效,安全性和生物标志物分析

2023-03-049
OAAI
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics

在常规诊断中,原发性未知癌症患者的完整基因组表征

2022-12-0115
OAAI
Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity
2018-07-2583
OA